What is ALIAXIN GP
ALIAXIN GP (Global Performance) is a sterile, monophasic dermal filler containing **cross-linked hyaluronic acid** at 25 mg/mL. It's delivered in two pre-filled 1 mL syringes, accompanied by four sterile needles (27G ×13 mm and 27G ×19 mm) :contentReference[oaicite:1]{index=1}.
- Type: Non-animal-derived, pharmaceutically pure, viscoelastic gel designed for intradermal/subcutaneous application.
- Indications: Correction of moderate-to-deep facial wrinkles (e.g., nasolabial folds, marionette lines), volume restoration in cheeks, chin, and lips, and treatment of acne scars :contentReference[oaicite:2]{index=2}.
- Benefits: Monophasic formula ensures smooth tissue integration; reliable results lasting 6–12 months :contentReference[oaicite:3]{index=3}.
- Advantages: High cohesivity, balance of hydration, voluminous lift, and soft, natural outcomes :contentReference[oaicite:4]{index=4}.
ALIAXIN GP is a versatile filler used by aesthetic professionals to restore facial volume and contour while maintaining natural facial expression and feel.
How to use ALIAXIN GP
Administration of ALIAXIN GP must be performed by qualified medical professionals under aseptic conditions.
- Preparation: Inspect packaging/syringe for damage; cleanse skin with alcohol-based disinfectant; avoid benzalkonium chloride :contentReference[oaicite:5]{index=5}.
- Injection technique: Use needles or cannulas. Inject into mid-to-deep dermis or subcutaneous plane using linear threading, bolus, or fanning techniques depending on anatomy and area :contentReference[oaicite:6]{index=6}.
- Treated areas: Nasolabial folds, marionette lines, glabellar folds, chin, cheeks, forehead, and lips :contentReference[oaicite:7]{index=7}.
- Dosage: Typically 1 mL per syringe per session; practitioners may use both syringes depending on targeted area volume :contentReference[oaicite:8]{index=8}.
- Post-procedure: Gentle massage, ice application, avoid strenuous activity/makeup for 24 hours :contentReference[oaicite:9]{index=9}.
- Follow-up: Assess results in 2–4 weeks; touch-ups may be performed if necessary.
- Documentation: Record batch numbers, injection sites, volumes for traceability per medical device protocols :contentReference[oaicite:10]{index=10}.
Precision, hygiene, and documentation are essential to ensure patient safety and predictable outcomes.
Mode of Action ALIAXIN GP
ALIAXIN GP operates through physical and biochemical mechanisms:
- Mechanical support: Cross-linked HA gel provides structural volume in dermis, smoothing wrinkles and restoring contours :contentReference[oaicite:11]{index=11}.
- Hydration: HA retains up to 1,000× its weight in water, enhancing skin hydration and elasticity :contentReference[oaicite:12]{index=12}.
- Tissue integration: Monophasic HA blends with tissue, minimizing nodules and creating a natural feel :contentReference[oaicite:13]{index=13}.
- Stimulation: HA may promote collagen synthesis, strengthening extracellular matrix and improving skin quality :contentReference[oaicite:14]{index=14}.
- Biodegradation: HA is enzymatically broken down, with visible effects lasting approximately 6–12 months :contentReference[oaicite:15]{index=15}.
The combination of volume restoration and hydration improves both cosmetic appearance and tissue health.
ALIAXIN GP Interactions ALIAXIN GP
Due to its localized application, ALIAXIN GP shows minimal systemic drug interactions, but several local considerations are essential.
- Antiseptics: Avoid benzalkonium chloride to prevent HA precipitation; alcohol-based solutions are recommended :contentReference[oaicite:16]{index=16}.
- Anticoagulants/antiplatelets: May increase bruising or bleeding risk after injection :contentReference[oaicite:17]{index=17}.
- NSAIDs/aspirin: Can exacerbate bleeding/bruising post-injection.
- Concurrent aesthetic procedures: Delay chemical peels, laser treatments, or microdermabrasion near injection site for ≥1 week :contentReference[oaicite:18]{index=18}.
- Hyaluronidase: Can reverse HA, used in complication management (e.g., vascular compromise) :contentReference[oaicite:19]{index=19}.
- Vaccinations: Avoid facial filler injection at same site around vaccine administration; monitor for inflammation :contentReference[oaicite:20]{index=20}.
Proper planning around co-medications and procedures ensures safety and recovery ease.
Dosage of ALIAXIN GP
- Volume: 1 mL per syringe; two syringes may be used across multiple zones per session :contentReference[oaicite:21]{index=21}.
- Injection depth: Mid-to-deep dermal or subcutaneous layer depending on area—deeper for volume, superficial for fine lines :contentReference[oaicite:22]{index=22}.
- Treated areas & typical dosing:
- Nasolabial folds / marionette lines: 0.5–1 mL per side.
- Cheeks/chin: 0.5–2 mL depending on volume deficit.
- Lips: small aliquots for natural shape, typically ≤1 mL.
- Session plan: Single treatment with optional enhancement in 2–4 weeks.
- Maintenance: Repeat every 6–12 months based on degradation and patient needs :contentReference[oaicite:23]{index=23}.
- Safety measure: Avoid intravascular injection; aspirate before injecting; inject slowly.
A nuanced dosing strategy ensures natural, effective, and safe aesthetic outcomes.
Possible side effects of ALIAXIN GP
ALIAXIN GP is well tolerated. Most adverse effects are localized and transient:
- Common (within 24–72 hrs): Redness, mild swelling, bruising, tenderness, itch—typically resolve in ≤1 week :contentReference[oaicite:24]{index=24}.
- Less common: Localized lumps or nodules; usually resolve or can be massaged out; possible sterile granulomas; infection is rare :contentReference[oaicite:25]{index=25}.
- Serious (rare): Vascular occlusion (vision loss, skin necrosis), allergic reactions—require immediate management :contentReference[oaicite:26]{index=26}.
- General: Headache, temporary discomfort at injection sites.
Practitioners should monitor for red flags and manage complications promptly, including use of hyaluronidase if vascular compromise occurs.
ALIAXIN GP Contraindications ALIAXIN GP
- Absolute:
- Known hypersensitivity to HA or lidocaine (if included) :contentReference[oaicite:27]{index=27}.
- Active infection or inflammation at treatment site :contentReference[oaicite:28]{index=28}.
- Bleeding disorders / anticoagulant therapy – relative contraindication :contentReference[oaicite:29]{index=29}.
- Relative:
- Pregnancy or breastfeeding – safety data limited :contentReference[oaicite:30]{index=30}.
- Autoimmune disorders – clinical judgment needed.
- History of keloid or poor wound healing.
- Recent facial cosmetic procedures – allow healing before injection.
Proper screening is key for safe application and reduced complication risks.
Storage of ALIAXIN GP
- Temperature: Store between 2 °C and 28 °C (ideally 2–25 °C); do not freeze :contentReference[oaicite:31]{index=31}.
- Packaging: Keep in original sealed blister until use; protect from light and moisture.
- Sterility: Single-use syringes; dispose of any unused content.
- Expiry: Use before printed date; discard open or expired product.
- Disposal: Sharps and materials should be disposed in appropriate medical waste containers.
Following storage guidelines preserves the gel’s quality and ensures safe use.
ALIAXIN GP features an exceptional active ingredient renowned for its potent effects, comprising Hyaluronic acid. This powerful formulation provides a superior solution for addressing diverse health concerns. With 0.025 concentration and an easily manageable Injection Solution for, it remains a preferred option for countless individuals seeking effective treatment.
Introduction
All you need to know about ALIAXIN GP .
Welcome to Dwaey, specifically on ALIAXIN GP page.
This medicine contains an important and useful components, as it consists of Hyaluronic acid.
ALIAXIN GP is available in the market in concentration 0.025 and in the form of Injection Solution for.
ROSE PHARMA SA is the producer of ALIAXIN GP and it is imported from SWITZERLAND,
The most popular alternatives of ALIAXIN GP are listed downward .
-
Active Substance
-
Size
2 s[2x1ML Pre-filled Syringe]
-
Indications
- No indications available.
-
Type
-
Company
Frequently Asked Questions
ALIAXIN GP should be stored according to the instructions provided by ROSE PHARMA SA.
In general, it is recommended to store ALIAXIN GP in a cool, dry place, away from direct sunlight
and out of the reach of children.
The duration of treatment with ALIAXIN GP may vary depending on the condition being treated
and the guidance of your healthcare provider. It is important to follow the prescribed treatment
plan and continue taking ALIAXIN GP for the recommended duration, even if your symptoms improve.
If you have any concerns or questions about the duration of treatment, consult your healthcare provider.
It is important to check with your healthcare provider or read the medication label for specific
instructions regarding alcohol consumption while taking ALIAXIN GP. Some medications, including
ALIAXIN GP, may have interactions with alcohol that can reduce effectiveness, increase side
effects, or pose other risks to your health. It is best to follow the guidance provided by your
healthcare professional.
If you miss a dose of ALIAXIN GP, take it as soon as you remember. However, if it is close
to the time for your next scheduled dose, skip the missed dose and continue with your regular dosing
schedule. Do not take a double dose to make up for a missed one unless advised by your healthcare provider.
No, do not stop taking ALIAXIN GP without consulting your healthcare provider, even if your
symptoms improve. It is important to complete the full course of treatment as prescribed. Stopping
the medication prematurely may lead to a relapse or incomplete resolution of the condition. If you
have concerns about the duration of treatment, consult your healthcare provider for guidance.
It is important to consult your healthcare provider before taking ALIAXIN GP if you are
pregnant or breastfeeding. They will be able to assess the potential risks and benefits based on your
specific situation. Please note that the safety and suitability of ALIAXIN GP during pregnancy
or breastfeeding may depend on the active substance [Active Substance], concentration 0.025,
and the specific recommendations of ROSE PHARMA SA.
The effects of ALIAXIN GP on your ability to drive or operate machinery can vary depending on
the active substance [Active Substance], concentration 0.025, and individual factors.
Some medications may cause drowsiness, dizziness, or other side effects that can impair your judgment
or coordination. It is important to read the medication label or consult your healthcare provider to
understand any potential effects on your ability to perform tasks that require alertness.
The instructions for taking ALIAXIN GP with or without food may vary depending on the medication
and the recommendations of ROSE PHARMA SA. Some medications may be more effective when taken with
food to enhance absorption or reduce stomach irritation, while others may need to be taken on an empty
stomach for optimal absorption. Read the medication label or consult your healthcare provider for specific instructions.
The use of ALIAXIN GP in children or elderly individuals may depend on various factors, including
the specific medication, type Injection Solution for, and the recommendations of ROSE PHARMA SA. Some
medications may have specific dosing instructions or precautions for these age groups. Consult your
healthcare provider or read the medication label for information regarding the safe and appropriate use
of ALIAXIN GP in children or elderly individuals.
Dwaey
All medical information published on the Dwaey website aims to increase medical awareness and health education among users. However, it is not a substitute for professional medical advice. Always consult with a specialist doctor. We strongly advise against using any information or medicine found on the site without referring to your healthcare provider.
Related Products
0 Comments